Renalase, a catecholamine-metabolising enzyme?
Recently, a new FAD-dependent amine oxidase, renalase, was described. It was secreted by the kidney into the blood and shown to have significant cardiovascular actions, which were attributed to its catecholamine-metabolising activity. The authors concluded that renalase might be an important regulatory factor in human (patho)physiology. The catecholamine-metabolising activity of renalase in plasma contrasts with previous investigations where catecholamines were found to be stable in human plasma, provided autoxidation is prevented by an antioxidant. The claim of catecholamine-metabolising activity of renalase was based on the generation of H(2)O(2) during incubation of the enzyme with catecholamines. Careful inspection and calculations of the data lead to the conclusion that the rate of H(2)O(2) generation is far too low to be ascribed to enzymatic conversion of catecholamines by renalase. Renalase may well have important cardiovascular functions, but there is no proof that its actions are mediated through catecholamine-metabolising activity.
Boomsma
F
F
Department of Internal Medicine, Section of Vascular Pharmacology, Erasmus MC, Rotterdam, The Netherlands. f.boomsma@erasmusmc.nl
Tipton
K F
KF
D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000294:innervation / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D007668:Kidney / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*
D002395:Catecholamines; D006861:Hydrogen Peroxide; D008995:Monoamine Oxidase; C521557:renalase